Clinical Trials Logo

Filter by:
NCT ID: NCT05433272 Not yet recruiting - COVID-19 Clinical Trials

Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated

Start date: August 10, 2023
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, active-controlled phase Ⅲ clinical trial.The purpose of this study is to evaluate the immunogenicity and safety of one booster dose of trivalent COVID-19 vaccine (vero cell), inactivated, prototype strain, delta strain and omicron strain in healthy people aged 3 years old and above and have completed two or three doses of CoronaVac® in Colombia.

NCT ID: NCT05720351 Not yet recruiting - Bariatric Surgery Clinical Trials

Alveolar Recruitment Maneuvers on Reduction of Lung Atelectasis in Bariatric Surgery by Using Lung Ultrasound Score

Start date: August 10, 2023
Phase: N/A
Study type: Interventional

The study aims to compare the staircase alveolar recruitment maneuver with PEEP titration versus sustained inflation alveolar recruitment maneuver by using lung ultrasound score as an indicator of improving lung atelectasis in bariatric surgery

NCT ID: NCT05793333 Not yet recruiting - Endometrial Cancer Clinical Trials

Predictors of Node Positivity in Endometrial Cancer

Start date: August 10, 2023
Phase:
Study type: Observational

To investigate the role of histological and moleculr profile of endometrial cancer patietns in predicting the risk of nodal metastases in endoemtrila cancer patients.

NCT ID: NCT05814484 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Role of Inhaler Adherence and Blood Eosinophil Count in Exacerbations of COPD

INCLINE
Start date: August 10, 2023
Phase:
Study type: Observational

This is an observational study examining inhaler adherence and subsequent changes in blood eosinophil count in exacerbations of Chronic obstructive pulmonary disease (COPD) population. The study will run for 6 months as an observation period. Passive inhaler adherence monitoring will be done electronically via inhaler sensors connected to mobile Apps, and collecting symptoms questionnaires, diary of exacerbation events and trial visits predominantly in remote fashion. It will explore the feasibility of digital platform in clinical practice to collect the adherence data along with exacerbation events.

NCT ID: NCT05933512 Not yet recruiting - COVID-19 Clinical Trials

A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

Start date: August 10, 2023
Phase: Phase 2
Study type: Interventional

This study is a phase Ⅱ clinical trial to evaluate the safety and immunogenicity of SCTV01E-2 in people of different ages who had been vaccinated with COVID-19 vaccines. A total of at least 600 subjects aged 3 years and older who were previously vaccinated with domestically licensed SARS-CoV-2 vaccines with recommended doses and immunization schedules are planned to be enrolled. Group A included 400 patients aged 18 years and above, and group B included 200 patients aged 3-17 years.

NCT ID: NCT05962671 Not yet recruiting - Anesthesia Clinical Trials

Opioid-sparing Versus Sevoflurane Anesthesia on Early Postoperative Hypoventilation in Laparoscopic Bariatric Surgery

Start date: August 10, 2023
Phase: Phase 4
Study type: Interventional

Determine the incidence of early post-operative hypoventilation in post-anesthesia care unit (PACU) in patients undergoing laparoscopic bariatric surgery under opioid-sparing compared with sevoflurane-based anesthesia.

NCT ID: NCT05966701 Not yet recruiting - Arthritis, Gouty Clinical Trials

The MAD Study of SSGJ-613 in Healthy Subjects

Start date: August 10, 2023
Phase: Phase 1
Study type: Interventional

To evaluate the safety and tolerability of SSGJ-613 after multiple subcutaneous injections in healthy subjects.

NCT ID: NCT05978401 Not yet recruiting - Clinical trials for Advanced Non-Small Cell Lung Cancer

Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer

Start date: August 10, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, open Phase I/II study. The trial consists of two parts, Part1 is a dose-escalation/expansion study, Part2 is a combination of GLS-010 and GLS-010+GLS-012 with standard chemotherapy for advanced non-small-cell lung cancer respectively to assess preliminary efficacy at the combination dose.

NCT ID: NCT05979402 Not yet recruiting - Healthy Clinical Trials

The Effect of Pressure Ulcer Education on the Knowledge Level of the Relatives of the Patients

Start date: August 10, 2023
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial, which included pretest and posttest, was to examine the effectiveness of pressure ulcer prevention and care education given to caregivers of patients treated in a palliative care clinic. The key questions it aims to answer are: - Does the routine clinical training given in the palliative care clinic have an effect on the knowledge level of patients' relatives about pressure ulcers? - Does the pressure ulcer education given to the relatives of patients treated in the palliative care clinic have an effect on the level of knowledge about pressure ulcers? Participants will participate in an educational activity on pressure ulcers. Researchers will compare whether pressure ulcer training given to palliative care patient relatives is effective compared to routine service training with lecture, question-answer and presentation method.

NCT ID: NCT05980390 Not yet recruiting - IL35, Vitiligo Clinical Trials

IL35 Level in Vitiligo

Start date: August 10, 2023
Phase:
Study type: Observational

The aim of this observational study is to evaluate the level of the IL-35 protein in tissue biopsy from patients with active & stable vitiligo.